Although previous studies have highlighted that the dysregulation of insulin-signaling in obesity or Type-II diabetes is a risk factor for the development of neurological diseases [17, 65, 82], these studies suggest that simply reducing insulin signaling in the adult CNS is not a causative factor for neural decline [80, 81]. This evidence concerns the gene INS and nervous system disorder.